BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yuefang Ye, Xi Jin, Min Yue, Shaohua Chen, Chaohui Yu, Youming Li. The protective effect of oral colitis-derived proteins in a murine model of inflammatory bowel disease is associated with an increase in γδ T cells in large intestinal mucosaInternational Journal of Colorectal Disease 2010; 25(9): 1055 doi: 10.1007/s00384-010-0975-9
2
Yaron Ilan. Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel diseaseClinical & Translational Immunology 2016; 5(1): e60 doi: 10.1038/cti.2015.47
3
Massimo Fusconi, Gianna Pulice, Flora Ippoliti, Romina Mastronicola, Giovanni Ralli, Marco de Vincentiis. Modification of lymphocyte subsets in patients with rhinoscleromaAmerican Journal of Otolaryngology 2006; 27(6): 401 doi: 10.1016/j.amjoto.2006.03.013
4
Yaron Ilan. Oral tolerance: Can we make it work?Human Immunology 2009; 70(10): 768 doi: 10.1016/j.humimm.2009.06.018
5
Eran Israeli, Ehud Zigmond, Gadi Lalazar, Athalia Klein, Nilla Hemed, Eran Goldin, Yaron Ilan. Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trialWorld Journal of Gastroenterology 2015; 21(18): 5685-5694 doi: 10.3748/wjg.v21.i18.5685
6
Paolo Giuffrida, Sara Cococcia, Mariangela Delliponti, Marco Vincenzo Lenti, Antonio Di Sabatino. Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel DiseaseCells 2019; 8(5): 397 doi: 10.3390/cells8050397
7
Maya Margalit, Eran Israeli, Oren Shibolet, Ehud Zigmond, Athalia Klein, Nilla Hemed, James J. Donegan, Elazar Rabbani, Eran Goldin, Yaron Ilan. A Double-Blind Clinical Trial for Treatment of Crohn's Disease by Oral Administration of Alequeltm, A Mixture of Autologous Colon-Extracted Proteins: A Patient-Tailored ApproachThe American Journal of Gastroenterology 2006; 101(3): 561 doi: 10.1111/j.1572-0241.2006.00441.x
8
Jae Geun Hyun, Terrence A. Barrett. Oral Tolerance Therapy in Inflammatory Bowel DiseaseThe American Journal of Gastroenterology 2006; 101(3): 569 doi: 10.1111/j.1572-0241.2006.00437.x
9
Ad A. van Bodegraven, Cisca Wijmenga. Genomic and Personalized Medicine2009; : 1040 doi: 10.1016/B978-0-12-369420-1.00086-X
10
Femke Broere, Lotte Wieten, Elles I. Klein Koerkamp, Joel A. G. van Roon, Teun Guichelaar, Floris P. J. G. Lafeber, Willem van Eden. Oral or Nasal Antigen Induces Regulatory T Cells That Suppress Arthritis and Proliferation of Arthritogenic T Cells in Joint Draining Lymph NodesThe Journal of Immunology 2008; 181(2): 899 doi: 10.4049/jimmunol.181.2.899
11
G.R. Lichtenstein. A Double-Blind Clinical Trial for Treatment of Crohn's Disease by Oral Administration of Alaquel™, A Mixture of Autologous Colon-Extracted Proteins: A Patient-Tailored ApproachYearbook of Gastroenterology 2007; 2007: 129 doi: 10.1016/S0739-5930(08)70108-9
12
Eran Israeli, Yaron Ilan. Review: Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s diseaseTherapeutic Advances in Gastroenterology 2010; 3(1): 23 doi: 10.1177/1756283X09351733
13
Ross John Porter, Caroline Andrews, Daniel Paul Brice, Scott Kenneth Durum, Mairi Hall McLean. Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?Inflammatory Bowel Diseases 2018; 24(10): 2123 doi: 10.1093/ibd/izy230